Moreover, increased expression of ERVFRD-1 in cancers from the Cancer Genome Atlas (TCGA) with ERVFRD-1 fusions suggested that ERVFRD-1 promoted tumor growth by inhibiting the anti-tumor immune response of the host mice. Here, ERVFRD-1 is linked to neoplasm.